دانلود رایگان مقاله مارتین شکرلی دقیقا کیست؟

POINT Martin Shkreli is many things, but he is not an entrepreneur (Plummer & Mitchell) Martin Shkreli, the founder of Retrophin and former CEO of Turing Pharmaceuticals, has been scorned by journalists and policymakers for what widely is seen as a reprehensible act of price gouging, the likes of which has rarely been seen in American business. For his efforts, Mr. Shkreli has been called arrogant, brash, evil, greedy, haughty, supercilious, and. . .entrepreneur. While he may rightly deserve most of these labels, he does not deserve the title of entrepreneur. In our eyes, entrepreneurs create new value, and Mr. Shkreli’s actions–—specifically, buying the rights to older drugs, adding or changing nothing, and hiking up their prices exorbitantly–—do not qualify. Entrepreneurs create new value through creativity, ingenuity, innovation, novelty, problem solving, and persistence. While some of the value created by entrepreneurs takes the form of private returns they and their investors receive, it also exists in the new products, services, innovations, ways of doing business, and jobs entrepreneurs create. Our view of entrepreneurship embraces its many and varied forms, but also provides a level of clarity in the case of Mr. Shkreli. For starters, price gouging is not entrepreneurship because it does not create new value. COUNTERPOINT Martin Shkreli is an entrepreneur, albeit an immoral one (McMullen) Professors Plummer and Mitchell make an interesting case against the media’s depiction of Martin Shkreli as an entrepreneur. But morally despicable as his actions may be and as much as I would like to disassociate him from anything related to entrepreneurship, it is simply not possible given an understanding of entrepreneurship as the creation of new value.